标题
Incretins: Their physiology and application in the treatment of diabetes mellitus
作者
关键词
-
出版物
DIABETES-METABOLISM RESEARCH AND REVIEWS
Volume 30, Issue 5, Pages 354-371
出版商
Wiley
发表日期
2013-12-04
DOI
10.1002/dmrr.2501
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical effects of once-weekly exenatide for the treatment of type 2 diabetes mellitus
- (2013) G. J. Ryan et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
- (2013) A. E. Butler et al. DIABETES
- Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595-2604
- (2013) S. S. Engel et al. DIABETES
- Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595-2604
- (2013) R. J. Heine et al. DIABETES
- Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives
- (2013) B. Ahrén DIABETES & METABOLISM
- Do GLP-1-Based Therapies Increase Cancer Risk?
- (2013) M. A. Nauck et al. DIABETES CARE
- Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2011
- (2013) DIABETES RESEARCH AND CLINICAL PRACTICE
- AACE Comprehensive Diabetes Management Algorithm 2013 Endocrine Practice
- (2013) Héctor Tamez-Pérez et al. Endocrine Practice
- American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement
- (2013) Alan Garber et al. Endocrine Practice
- Clinical utility of insulin and insulin analogs
- (2013) Ahter D. Sanlioglu et al. Islets
- Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus
- (2013) Sonal Singh et al. JAMA Internal Medicine
- Pancreatitis: A Potential Complication of Liraglutide?
- (2012) Andrea S Franks et al. ANNALS OF PHARMACOTHERAPY
- GLP-1 Receptor Agonist Effects on Normal and Neoplastic Pancreata
- (2012) Michael Goggins DIABETES
- Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12DMouse Model
- (2012) Belinda Gier et al. DIABETES
- The Human GLP-1 Analog Liraglutide and the Pancreas
- (2012) Niels C.B. Nyborg et al. DIABETES
- GLP-1–Based Therapies and the Exocrine Pancreas: More Light, or Just More Heat?
- (2012) Edwin A.M. Gale DIABETES
- No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks
- (2012) K. Tatarkiewicz et al. DIABETES OBESITY & METABOLISM
- Impairment of GLP1-induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia
- (2012) S. Herzberg-Schäfer et al. DIABETES OBESITY & METABOLISM
- By the numbers: New estimates from the IDF Diabetes Atlas Update for 2012
- (2012) Leonor Guariguata DIABETES RESEARCH AND CLINICAL PRACTICE
- A Review on the Association between Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer
- (2012) Wei-Yih Chiu et al. Experimental Diabetes Research
- Insulin gene therapy from design to beta cell generation
- (2012) Ahter D. Sanlioglu et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- GLP1-derived nonapeptide GLP1(28–36)amide protects pancreatic β-cells from glucolipotoxicity
- (2012) Zhengu Liu et al. JOURNAL OF ENDOCRINOLOGY
- Therapeutic potential of VIP vs PACAP in diabetes
- (2012) Ahter D Sanlioglu et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction
- (2012) Sheldon Russell International Journal of Clinical Pharmacy
- Acute Pancreatitis Associated with Liraglutide
- (2011) Phillip H Lee et al. ANNALS OF PHARMACOTHERAPY
- Activation of the GLP-1 Receptor Signalling Pathway: A Relevant Strategy to Repair a Deficient Beta-Cell Mass
- (2011) Bernard Portha et al. Experimental Diabetes Research
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
- (2011) Michael Elashoff et al. GASTROENTEROLOGY
- The Safety of Incretin-Based Therapies—Review of the Scientific Evidence
- (2011) Daniel J. Drucker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide
- (2011) Laszlo Hegedüs et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Incretin Receptors in Non-Neoplastic and Neoplastic Thyroid C Cells in Rodents and Humans: Relevance for Incretin-Based Diabetes Therapy
- (2011) Beatrice Waser et al. NEUROENDOCRINOLOGY
- GLP-1 analogs containing disulfide bond exhibited prolonged half-life in vivo than GLP-1
- (2011) Ying Li et al. PEPTIDES
- Clinical Implications of Exenatide as a Twice-Daily or Once-Weekly Therapy for Type 2 Diabetes
- (2011) Vanita R. Aroda et al. POSTGRADUATE MEDICINE
- Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents
- (2010) Krystyna Tatarkiewicz et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Association of Pancreatitis with Glucagon-Like Peptide-1 Agonist Use
- (2010) Sarah L Anderson et al. ANNALS OF PHARMACOTHERAPY
- GLP-1-Based Therapy for Diabetes: What You Do Not Know Can Hurt You
- (2010) P. C. Butler et al. DIABETES CARE
- Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation
- (2010) Lotte Bjerre Knudsen et al. ENDOCRINOLOGY
- Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis
- (2010) S. S. Engel et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy
- (2010) Mary Parks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thyroid Cancer Incidence Patterns in the United States by Histologic Type, 1992–2006
- (2010) Briseis Aschebrook-Kilfoy et al. THYROID
- Glucagon-Like Peptide-1 Receptor Activation Modulates Pancreatitis-Associated Gene Expression But Does Not Modify the Susceptibility to Experimental Pancreatitis in Mice
- (2009) J. A. Koehler et al. DIABETES
- Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes: A randomized controlled trial exploring weekly, biweekly, and monthly dosing
- (2009) J. Rosenstock et al. DIABETES CARE
- Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas
- (2009) J. S. Nachnani et al. DIABETOLOGIA
- Collateral damage: the conundrum of drug safety
- (2009) E. A. M. Gale DIABETOLOGIA
- Pancreatic Duct Glands Are Distinct Ductal Compartments That React to Chronic Injury and Mediate Shh-Induced Metaplasia
- (2009) Oliver Strobel et al. GASTROENTEROLOGY
- Glucose Sensing in L Cells: A Primary Cell Study
- (2008) Frank Reimann et al. Cell Metabolism
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Pharmacokinetics and Pharmacodynamic Effects of Oral GLP-1 and PYY3-36: A Proof-of-concept Study in Healthy Subjects
- (2008) C Beglinger et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion
- (2008) S. Edfalk et al. DIABETES
- Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells
- (2008) H. E. Parker et al. DIABETOLOGIA
- GPR119: “Double-Dipping” for Better Glycemic Control
- (2008) L. Lauffer et al. ENDOCRINOLOGY
- A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release
- (2008) Zhi-Liang Chu et al. ENDOCRINOLOGY
- Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117
- (2008) Feng Qian et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeted Ablation of Glucose-dependent Insulinotropic Polypeptide-producing Cells in Transgenic Mice Reduces Obesity and Insulin Resistance Induced by a High Fat Diet
- (2008) Matthew C. Althage et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vaccination against GIP for the Treatment of Obesity
- (2008) Alma Fulurija et al. PLoS One
- Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice
- (2008) Haoran Su et al. PLoS One
- Measurements of Islet Function and Glucose Metabolism with the Dipeptidyl Peptidase 4 Inhibitor Vildagliptin in Patients with Type 2 Diabetes
- (2007) Koichiro Azuma et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart
- (2007) David P. Sonne et al. REGULATORY PEPTIDES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search